Table TDI-17. Route of administration of primary drug among new outpatient clients in 2004 – Part (iii) Percentage among clients with stimulants as primary drug

Country

Inject

Smoke/
inhale

Eat/ drink

Sniff

Others

Base
(known status)

Status unknown

Czech Republic

68.5

0.7

1.3

29.2

0.2

448

7

Denmark

1.4

0.0

31.1

67.6

0.0

148

30

Germany

1.2

8.2

59.3

23.7

7.5

2538

2668

Greece

0.0

22.2

77.8

0.0

0.0

9

0

Italy

0.0

0.0

100.0

0.0

0.0

201

35

Cyprus

0.0

0.0

100.0

0.0

0.0

4

0

Latvia

77.8

0.9

18.5

2.8

0.0

108

9

Hungary

9.8

0.0

67.5

1.3

21.4

459

0

Malta

0.0

0.0

100.0

0.0

0.0

6

2

Netherlands

1.9

9.1

38.1

48.3

2.6

464

58

Slovenia

0.0

0.0

100.0

0.0

0.0

6

0

Slovakia

43.0

23.3

7.0

11.6

15.1

86

3

Finland

61.4

0.7

18.6

19.3

0.0

145

4

Sweden

30.5

2.9

50.6

14.9

1.1

174

10

United Kingdom

20.4

2.6

69.0

6.3

1.7

1610

283

Bulgaria

0.0

0.0

25.0

75.0

0.0

8

0

 

 

 

 

 

 

 

 

Total

15.4

5.1

54.9

19.3

5.3

6414

3109

Notes:

Only countries where clients are reported with stimulants as primary drug are shown.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Source:

2005 Reitox national reports - TDI outpatient treatment centres

Data filter | tditab17c-en.xml